Glucocorticoid Receptor Status Is a Principal Determinant of Variability in the Sensitivity of Non–Small-Cell Lung Cancer Cells to Pemetrexed  Mugdha.

Slides:



Advertisements
Similar presentations
Nicotinamide Phosphoribosyltransferase: A Potent Therapeutic Target in Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor-Gene Mutation 
Advertisements

Inducible EGFR T790M-Mediated Gefitinib Resistance in Non-small Cell Lung Cancer Cells Does Not Modulate Sensitivity to PI103 Provoked Autophagy  Flavia.
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Cell Physiol Biochem 2013;32: DOI: /
Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy 
INHBA Overexpression Promotes Cell Proliferation and May Be Epigenetically Regulated in Esophageal Adenocarcinoma  Christopher W. Seder, MD, Wibisono.
The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib  Yiyu Zou, PhD, Yi-He.
The Epidermal Growth Factor Receptor-L861Q Mutation Increases Kinase Activity without Leading to Enhanced Sensitivity Toward Epidermal Growth Factor Receptor.
Inhibition of hypoxia-induced cyclooxygenase-2 by Korean Red Ginseng is dependent on peroxisome proliferator-activated receptor gamma  Heewon Song, Young.
EZH2 Promotes E2F-Driven SCLC Tumorigenesis through Modulation of Apoptosis and Cell-Cycle Regulation  Roland Hubaux, PhD, Kelsie L. Thu, BSc, Bradley.
Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer  Lanxi Song, MS, Matthew A. Smith, PhD,
Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition–mediated cell death in K-ras mutant lung cancer.
Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR- Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients.
Inactivation of Both FHIT and p53 Cooperate in Deregulating Proliferation-Related Pathways in Lung Cancer  Francesca Andriani, PharmD, Elena Roz, MD,
Soy Isoflavones Augment Radiation Effect by Inhibiting APE1/Ref-1 DNA Repair Activity in Non-small Cell Lung Cancer  Vinita Singh-Gupta, PhD, Michael.
Nicotine Induces Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor by α1 Nicotinic Acetylcholine Receptor–Mediated Activation in.
Neurotrophins and Their Receptors Stimulate Melanoma Cell Proliferation and Migration  Francesca Truzzi, Alessandra Marconi, Roberta Lotti, Katiuscia.
Membrane-Tethered Intracellular Domain of Amphiregulin Promotes Keratinocyte Proliferation  Stefan W. Stoll, Philip E. Stuart, Sylviane Lambert, Alberto.
Induction of E-Cadherin in Lung Cancer and Interaction with Growth Suppression by Histone Deacetylase Inhibition  Masatoshi Kakihana, MD, Tatsuo Ohira,
Molecular Therapy - Methods & Clinical Development
INHBA Overexpression Promotes Cell Proliferation and May Be Epigenetically Regulated in Esophageal Adenocarcinoma  Christopher W. Seder, MD, Wibisono.
Sarah A. Best, Amy N. Nwaobasi, Chrysalyne D. Schmults, Matthew R
Resistance to EGFR-TKI Can Be Mediated through Multiple Signaling Pathways Converging upon Cap-Dependent Translation in EGFR-Wild Type NSCLC  Manish R.
PTF1α/p48 and cell proliferation
Volume 118, Issue 4, Pages (April 2000)
Sarah A. Best, Amy N. Nwaobasi, Chrysalyne D. Schmults, Matthew R
Genetic Determinants of Pemetrexed Responsiveness and Nonresponsiveness in Non- small Cell Lung Cancer Cells  Ming-Fang Wu, MD, PhD, Yi-Min Hsiao, PhD,
A Histone Deacetylase Inhibitor LBH589 Downregulates XIAP in Mesothelioma Cell Lines Which is Likely Responsible for Increased Apoptosis With TRAIL  James.
The selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cells  Xia Luo, Ph.D., Ping Yin,
Chakradhari Sharan, Ph. D. , Sunil K. Halder, Ph. D
Volume 16, Issue 4, Pages (October 2009)
Large-Scale Screening and Molecular Characterization of EML4-ALK Fusion Variants in Archival Non–Small-Cell Lung Cancer Tumor Specimens Using Quantitative.
MET Increases the Sensitivity of Gefitinib-Resistant Cells to SN-38, an Active Metabolite of Irinotecan, by Up-Regulating the Topoisomerase I Activity 
Inducible EGFR T790M-Mediated Gefitinib Resistance in Non-small Cell Lung Cancer Cells Does Not Modulate Sensitivity to PI103 Provoked Autophagy  Flavia.
Folylpoly-Glutamate Synthetase Expression Is Associated with Tumor Response and Outcome from Pemetrexed-Based Chemotherapy in Malignant Pleural Mesothelioma 
Combining the Multitargeted Tyrosine Kinase Inhibitor Vandetanib with the Antiestrogen Fulvestrant Enhances Its Antitumor Effect in Non-small Cell Lung.
The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib  Yiyu Zou, PhD, Yi-He.
Hepatocyte Growth Factor Induces Resistance to Anti-Epidermal Growth Factor Receptor Antibody in Lung Cancer  Tadaaki Yamada, MD, PhD, Shinji Takeuchi,
How I Do It—Optimal Methodology for Multidirectional Analysis of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples  Takahiro Nakajima,
Nicotine Induces Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor by α1 Nicotinic Acetylcholine Receptor–Mediated Activation in.
Spleen Tyrosine Kinase Mediates EGFR Signaling to Regulate Keratinocyte Terminal Differentiation  Nan-Lin Wu, Duen-Yi Huang, Li-Fang Wang, Reiji Kannagi,
Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non– Small Cell Lung Cancer Xenograft Models  Josephine Hai, PhD, Shingo Sakashita,
Aromatase Inhibitor Exemestane has Antiproliferative Effects on Human Mesothelioma Cells  Daniela Stoppoloni, BSc, Luisa Salvatori, BSc, Annamaria Biroccio,
AT-101, a Pan-Bcl-2 Inhibitor, Leads to Radiosensitization of Non-small Cell Lung Cancer  Luigi Moretti, MD, Bo Li, MD, Kwang Woon Kim, PhD, Heidi Chen,
Interleukin-22 Is Frequently Expressed in Small- and Large-Cell Lung Cancer and Promotes Growth in Chemotherapy-Resistant Cancer Cells  Sebastian Kobold,
MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2  Ji-guang Zhang,
Fas-associating death domain protein overexpression induces apoptosis in lung cancer cells  Peter K.M. Kim, MD, Sang-Youel Park, PhD, Patrick P Koty,
Terameprocol (Tetra-O-Methyl Nordihydroguaiaretic Acid), an Inhibitor of Sp1-Mediated Survivin Transcription, Induces Radiosensitization in Non-small.
Genetic Determinants of Pemetrexed Responsiveness and Nonresponsiveness in Non- small Cell Lung Cancer Cells  Ming-Fang Wu, MD, PhD, Yi-Min Hsiao, PhD,
The Epidermal Growth Factor Receptor-L861Q Mutation Increases Kinase Activity without Leading to Enhanced Sensitivity Toward Epidermal Growth Factor Receptor.
Cell-Density-Dependent Regulation of Expression and Glycosylation of Dopachrome Tautomerase/Tyrosinase-Related Protein-2  Thomas J. Hornyak, Daniel J.
Discordant HER2 Exon 20 Mutation Status Determines a Differential Sensitivity to Afatinib  Chien-Hung Gow, MD, PhD, Wei-Yu Liao, MD, PhD, Yi-Nan Liu,
IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling  Yasushi.
Nicotinamide Phosphoribosyltransferase: A Potent Therapeutic Target in Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor-Gene Mutation 
Stat3-Targeted Therapies Overcome the Acquired Resistance to Vemurafenib in Melanomas  Fang Liu, Juxiang Cao, Jinxiang Wu, Kayleigh Sullivan, James Shen,
Activation of PPARγ leads to inhibition of anchorage-independent growth of human colorectal cancer cells  Jeffrey A. Brockman, Rajnish A. Gupta, Raymond.
Chadrick E. Denlinger, MD, Brian K. Rundall, DO, Michael D
Volume 39, Issue 3, Pages (September 2003)
Volume 127, Issue 4, Pages (October 2004)
MicroRNAs Dysregulation in Human Malignant Pleural Mesothelioma
IL-18 Downregulates Collagen Production in Human Dermal Fibroblasts via the ERK Pathway  Hee Jung Kim, Seok Bean Song, Jung Min Choi, Kyung Moon Kim,
Associations between TS, TTF-1, FR-α, FPGS, and Overall Survival in Patients with Advanced Non–Small-Cell Lung Cancer Receiving Pemetrexed Plus Carboplatin.
MET Increases the Sensitivity of Gefitinib-Resistant Cells to SN-38, an Active Metabolite of Irinotecan, by Up-Regulating the Topoisomerase I Activity 
Volume 18, Issue 3, Pages (March 2010)
Volume 70, Issue 5, Pages (September 2006)
Direct effects of dexamethasone on human podocytes
Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic.
The selective progesterone receptor modulator CDB4124 inhibits proliferation and induces apoptosis in uterine leiomyoma cells  Xia Luo, Ph.D., Ping Yin,
Preferential response of cancer cells to zebularine
Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy 
Presentation transcript:

Glucocorticoid Receptor Status Is a Principal Determinant of Variability in the Sensitivity of Non–Small-Cell Lung Cancer Cells to Pemetrexed  Mugdha Patki, MS, Shirish Gadgeel, MD, Yanfang Huang, MS, Thomas McFall, MS, Anthony F. Shields, MD, PhD, Larry H. Matherly, PhD, Gerold Bepler, MD, PhD, Manohar Ratnam, PhD  Journal of Thoracic Oncology  Volume 9, Issue 4, Pages 519-526 (April 2014) DOI: 10.1097/JTO.0000000000000111 Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 Differential effects of Dex on the expression of genes involved in pemetrexed action in A549 versus H1299 cells. A549 cells (A and C) and H1299 cells (B and D) were plated at 20% confluence in media containing charcoal-stripped serum for 24 hours for hormone depletion. Cells were then treated with either vehicle (ethanol) or Dex (100 nM) for 48 hours. Cells were harvested and total RNA extracted to measure mRNA levels by real-time RT-PCR (A and B). Whole cell lysates were also extracted from the cells to measure the protein levels of TS and DHFR by Western blot; GAPDH was used as the loading control (C and D). *p < 0.01. All the mRNA measurements were carried out using biological triplicate samples. Dex, dexamethasone; TS, thymidylate synthase; DHFR, dihydrofolate reductase; AICARFT, 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase; GARFT, glycinamide ribonucleotide formyltransferase; RFC, reduced folate carrier; PCFT, proton coupled folate transporter; FPGS, folyl-polyglutamate synthase; TK1, thymidine kinase 1; RQ, relative quantification. Journal of Thoracic Oncology 2014 9, 519-526DOI: (10.1097/JTO.0000000000000111) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 Effect of Dex on cell-cycle phase distribution in A549 and H1299 cells. A549 cells (A) and H1299 cells (B) were plated at 20% confluence in media containing charcoal-stripped serum for 24 hours for hormone depletion. Cells were then treated with either vehicle (ethanol) or Dex (100 nM) for 48 hours and harvested for flow cytometry analysis. The experiments were repeated at least three times. Within each experiment, the percent error for replicate samples was < 10%. The p values for Dex induced changes noted in the text were < 0.0001. Dex, dexamethasone. Journal of Thoracic Oncology 2014 9, 519-526DOI: (10.1097/JTO.0000000000000111) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 3 Reversibility of Dex effects in A549 cells. A549 cells were plated at 20% confluence in media containing charcoal-stripped serum for 24 hours for hormone depletion. Cells were then treated with either vehicle (ethanol) or Dex (100 nM). After 48 hours, Dex was removed by washing the cells twice and replacing with fresh media. Cells were cultured for additional periods of 24 hours and 48 hours. Cells were harvested for flow cytometry analysis (A). The experiments were repeated at least three times. Within each experiment, the percent error for replicate samples was < 10%. The p values for Dex induced changes noted in the text were < 0.0001. In parallel, cells were harvested for mRNA measurement by real-time reverse transcription polymerase chain reaction (B). *p < 0.01. All the mRNA measurements were carried out using biological triplicate samples. RQ, relative quantification; Dex, dexamethasone; TS, thymidylate synthase; DHFR, dihydrofolate reductase. Journal of Thoracic Oncology 2014 9, 519-526DOI: (10.1097/JTO.0000000000000111) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 4 Effect of restoring GRα on responsiveness to Dex in H1299 cells. H1299-GRα cells were generated as described under Materials and Methods. RNA extracted from A549 cells, H1299 cells, and H1299-GRα cells was used to measure the relative mRNA levels for GRα (A). H1299-GRα cells were plated at 20% confluence in media containing charcoal-stripped serum for 24 hours for hormone depletion. Cells were then treated with either vehicle (ethanol) or Dex (100 nM) for 48 hours. Cells were harvested for mRNA measurement by real-time reverse transcription polymerase chain reaction (B). *p < 0.01. In parallel, cells were harvested for cell-cycle analysis (C). The experiments were repeated at least three times. Within each experiment, the percent error for replicate samples was < 10 percent. The p values for Dex induced changes noted in the text were < 0.0001. All the mRNA measurements were carried out using biological triplicate samples. GR, glucocorticoid receptor; Dex, dexamethasone; RQ, relative quantification; TS, thymidylate synthase; DHFR, dihydrofolate reductase. Journal of Thoracic Oncology 2014 9, 519-526DOI: (10.1097/JTO.0000000000000111) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 5 Effect of knocking down p53 on responsiveness to Dex in H226 cells. The relative p53 expression levels in the parental H226 cells versus H226-p53KD cells were determined by real-time RT-PCR (A). H226-p53KD cells (B) or the parental H226 cells (C) were plated at 20% confluence in media containing charcoal-stripped serum for 24 hours for hormone depletion. Cells were then treated with either vehicle (ethanol) or Dex (100 nM) for 48 hours and then harvested for mRNA measurement by real-time RT-PCR. *p < 0.01. All the mRNA measurements were carried out using biological triplicate samples. Dex, dexamethasone; RT-PCR, reverse transcription polymerase chain reaction; TS, thymidylate synthase; DHFR, dihydrofolate reductase; TKI, thymidine kinase 1; RQ, relative quantification. Journal of Thoracic Oncology 2014 9, 519-526DOI: (10.1097/JTO.0000000000000111) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 6 Differential effects of Dex on growth inhibition by pemetrexed in A549 versus H1299 cells. A549 cells (A) and H1299 cells (B) were plated in six replicate wells in 96-well plates in media containing charcoal-stripped serum as described under Materials and Methods for MTT assays. Twenty-four hours after plating, the cells were treated with vehicle (ethanol) or Dex (100 nM) for 72 to 96 hours. The cells were exposed to pemetrexed (5 μM) or vehicle (water) for a 24-hour window in the midst of the Dex (or vehicle) treatment. MTT assays were performed on the indicated days, beginning with the day of pemetrexed treatment (day 0). At each time point, the ratio of the absorbance for pemetrexed treatment to its vehicle control was used to determine the percentage of viable cells. Dex, dexamethasone; MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide. Journal of Thoracic Oncology 2014 9, 519-526DOI: (10.1097/JTO.0000000000000111) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 7 Influence of Dex on inhibition of colony formation by pemetrexed in relation to GRα status. A549 cells (A and D), H1299 cells (B and E), and H1299-GRα cells (C and F) were first plated at 20% confluence in 10-cm dishes in media containing charcoal-stripped serum for hormone depletion. Twenty-four hours later cells were treated with vehicle (ethanol) or Dex (100 nM) for 72 to 96 hours. The cells were exposed to pemetrexed (5 μM) or vehicle (water) for a 24-hour window in the midst of the Dex (or vehicle) treatment. The cells were then plated for the colony-formation assay as described under Materials and Methods. After the colonies were formed, they were stained with crystal violet. The colony counts from replicate wells are represented in form of histograms (D–F). *,**p < 0.0001. Dex, dexamethasone; GR, glucocorticoid receptor. Journal of Thoracic Oncology 2014 9, 519-526DOI: (10.1097/JTO.0000000000000111) Copyright © 2014 International Association for the Study of Lung Cancer Terms and Conditions